Erratum: Promising in vitro anti-alzheimer properties for a ruthenium(iii) complex (ACS Med. Chem. Lett. (2013) 4 (329-332). DOI: 10.1021/ml3003567);Promising in Vitro anti-alzheimer properties for a ruthenium(III) complex

ACS Medicinal Chemistry Letters

Volumn 4, Issue 3, 2013, Pages 329-332

  Messori, Luigi ^a   Camarri, Michela ^b   Ferraro, Teresa ^b   Gabbiani, Chiara ^c   Franceschini, Davide ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Siena Biotech SpA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer's disease; ruthenium(III) complex; amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; INDAZOLIUM TETRACHLOROBIS(INDAZOLE)RUTHENATE; NAMI A; NOOTROPIC AGENT; PMRU 20; PRMN 20; RUTHENIUM COMPLEX; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CYTOTOXICITY; ELECTROSPRAY MASS SPECTROMETRY; IN VITRO STUDY; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 84875139371     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400390c     Document Type: Erratum

References (21)

1. Selkoe, D. J. Alzheimer's disease: Genes, proteins, and therapy Physiol. Rev. 2001, 81, 741-766 (Pubitemid 32267077)
2. Hardy, J. A.; Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis Science 1992, 256, 184-185
3. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002, 297, 353-356 (Pubitemid 34790756)
4. Torok, B.; Dasgupta, S.; Torok, M. Chemistry of small molecule inhibitors in self-assembly of Alzheimer's disease related amyloid-beta peptide Curr. Bioact. Compd. 2008, 4, 159-174
5. Barnham, K. J.; Kenche, V. B.; Ciccotosto, G. D.; Smith, D. P.; Tew, D. J.; Liu, X.; Perez, K.; Cranston, G. A.; Johanssen, T. J.; Volitakis, I.; Bush, A. I.; Masters, C. L.; White, A. R.; Smith, J. P.; Cherny, R. A.; Cappai, R. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 6813-6818 (Pubitemid 351754487)
6. Kenche, V. B.; Barnham, K. J. Alzheimer's disease & metals: therapeutic opportunities Br. J. Pharmacol. 2011, 163, 211-219
7. Valensin, D.; Gabbiani, C.; Messori, L. Metal compounds as inhibitors of β-amyloid aggregation. Perspectives for an innovative metallotherapeutics on Alzheimer's disease Coord. Chem. Rev. 2012, 256, 2357-2366
8. Dyson, H. J. Expanding the proteome: disordered and alternatively folded proteins Q. Rev. Biophys. 2011, 44, 467-518
9. Fuxreiter, M. Fuzziness: linking regulation to protein dynamics Mol. Biosyst. 2012, 8, 168-77
10. Zambelli, B.; Cremades, N.; Neyroz, P.; Turano, P.; Uversky, V. N.; Ciurli, S. Insights in the (un)structural organization of B.past.UreG, an intrinsically disordered GTPase enzyme Mol. Biosyst. 2012, 8, 220-8
11. Tompa, P. Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins FEBS J. 2009, 276, 5406-5415
12. Metallo, S. J. Intrinsically disordered proteins are potential drug targets Curr. Opin. Chem. Biol. 2010, 14, 481-8
13. Martin, D. M.; Chasteen, N. D.; Grady, J. K. Biochim. Biophys. Acta 1991, 1076, 252-8
14. Valensin, D.; Anzini, P.; Gaggelli, E.; Gaggelli, N.; Tamasi, G.; Cini, R.; Gabbiani, C.; Michelucci, E.; Messori, L.; Kozlowski, H.; Valensin, G. fac-{Ru(CO)(3)}(2+) selectively targets the histidine residues of the beta-amyloid peptide 1-28 Inorg. Chem. 2010, 49, 4720-2
15. Alessio, E.; Mestroni, G.; Bergamo, A.; Sava, G. Ruthenium antimetastatic agents Curr. Top. Med. Chem. 2004, 4, 1525-1535 (Pubitemid 39662663)
16. Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study Chem. Biodiversity 2008, 5, 2140-55
17. Mura, P.; Piccioli, F.; Gabbiani, C.; Camalli, M.; Messori, L. Structure-function relationships within Keppler-type antitumor ruthenium(III) complexes Inorg. Chem. 2005, 44, 4897-9
18. Pallitto, M. M.; Ghanta, J.; Heinzelman, P.; Kiessling, L. L.; Murphy, R. M. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation Biochemistry 1999, 38, 3570-3578
19. Uchikawa, O.; Fukatsu, K.; Suno, M.; Aono, T.; Doi, T. In vivo biological activity of antioxidative aminothiazole derivatives Chem. Pharm. Bull. 1996, 44, 2070-2077 (Pubitemid 26396756)
20. LeVine, H., III. Quantification of beta-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 1999, 309, 274-284
21. Michaelis, M. L.; Ansar, S.; Chen, Y.; Reiff, E. R.; Seyb, K. I.; Himes, R. H.; Audus, K. L.; Georg, G. I. β-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents J. Pharmacol. Exp. Ther. 2005, 312 (2) 659-68 (Pubitemid 40189564)